Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The structure of the endocrine pancreas in the sea bass (Dicentrarchus labrax L.) was studied with special reference to
glucagon
-immunoreactive cells. As described in most of the teleosts, the sea bass was found to have a diffuse pancreas. In the adult, endocrine cells were clustered in a principal islet and numerous accessory islets where the
glucagon
A cells were localized peripherally. Under electron microscopy, the A cells displayed a clear hyaloplasm with granules having typical spherical or polyhedral cores, as in other vertebrates. The maturation of the endocrine pancreas was monitored under rearing conditions. The endocrine pancreas appeared during the prelarval stage, 3 days after hatching, and consisted of a single cluster of morphologically similar cells, containing very small cytoplasmic granules. During the larval stage, cytodifferentiation resulted in modifications of cell shape and increased granule size. Typical granules appeared in 8-mm-long larvae. Cells immunoreactive with mammalian
glucagon
antibodies appeared only at the beginning of the juvenile stage (3 months/20 mm). Electron microscope observations revealed that the storage of hormone in numerous cytoplasmic granules began at this stage.
Gen
Comp Endocrinol 1990 Apr
PMID:Maturation of the endocrine pancreas in the sea bass, Dicentrarchus labrax L. (Teleostei): an immunocytochemical and ultrastructural study. I. Glucagon-producing cells. 218 22
Glucagon
increases the rate of glycogenolysis in in vitro cultures of hepatic tissue from the axolotl Ambystoma mexicanum. The hormone causes an increase in the concentration of cyclic AMP in the tissue which is followed by activation of glycogen phosphorylase and subsequent breakdown of glycogen and release of glucose from the tissue. Insulin counteracts the glycogenolytic effect of
glucagon
by inhibiting the increase in tissue cyclic AMP concentration brought about by
glucagon
. This inhibitory effect of insulin is not seen in the presence of the phosphodiesterase inhibitor IBMX and so it appears that the initial action of insulin is a stimulation of cyclic AMP phosphodiesterase activity which lowers the tissue concentration of cyclic AMP and so counters the actions of hormones that act by raising the tissue concentration of cyclic AMP. This model for the mode of action of insulin is supported by the finding that insulin also interferes with the glycogenolytic actions of adrenaline, a second hormone which acts by raising tissue cyclic AMP concentrations.
Gen
Comp Endocrinol 1986 Jan
PMID:Glucagon and insulin regulate in vitro hepatic glycogenolysis in the axolotl Ambystoma mexicanum via changes in tissue cyclic AMP concentration. 241 34
The effect of forskolin on ketogenesis and cAMP accumulation was studied in hepatocytes from euthyroid and hypothyroid rats. Forskolin stimulated ketogenesis, cAMP production and potentiated
glucagon
-stimulated cAMP accumulation on both euthyroid and hypothyroid groups. The ketogenic effect of
glucagon
was inhibited by forskolin in both groups. Also, forskolin,
glucagon
and methylisobutylxanthine (MIX) combined did not significantly increase ketogenesis.
Gen
Pharmacol 1986
PMID:Effect of forskolin on cAMP accumulation and ketogenesis in isolated hepatocytes. 243 Aug 56
Glucagon
-secreting alpha 2 cells were isolated from guinea pig pancreatic islets and used for electrophysiological studies of voltage-activated ionic conductances using the patch-clamp technique. The alpha 2 cells differed from beta cells in producing action potentials in the absence of glucose. The frequency of these potentials increased after addition of 10 mM arginine but remained unaffected in the presence of 5-20 mM glucose. When studying the conductances underlying the action potentials, we identified a delayed rectifying K+ current, an Na+ current, and a Ca2+ current. The K+ current activated above -20 mV and then increased with the applied voltage. The Na+ current developed at potentials above -50 mV and reached a maximal peak amplitude of 550 pA during depolarizing pulses to -15 mV. The Na+ current inactivated rapidly (tau h approximately 0.7 ms at 0 mV). Half-maximal steady state inactivation was attained at -58 mV, and currents could no longer be elicited after conditioning pulses to potentials above -40 mV. The Ca2+ current first became detectable at -50 mV and reached a maximal amplitude of 90 pA (in extracellular [Ca2+] = 2.6 mM) at about -10 mV. Unlike the Na+ current, it inactivated little or not at all. Membrane potential measurements demonstrated that both the Ca2+ and Na+ currents contribute to the generation of the action potential. Whereas there was an absolute requirement of extracellular Ca2+ for action potentials to be elicited at all, suppression of the much larger Na+ current only reduced the upstroke velocity of the spikes. It is suggested that this behavior reflects the participation of a low-threshold Ca2+ conductance in the pacemaking of alpha 2 cells.
J
Gen
Physiol 1988 Feb
PMID:Voltage-activated currents in guinea pig pancreatic alpha 2 cells. Evidence for Ca2+-dependent action potentials. 245 3
Concentrations of regulatory peptides in an extract of the intestine of the cyclostome, Myxine glutinosa (Atlantic hagfish), were measured by radioimmunoassay using 12 antisera of defined regional specificity that were raised against mammalian gastrointestinal peptides. The hagfish gut contained somatostatin-, cholecystokinin/gastrin-, C-terminal substance P-, and neurokinin A-like immunoreactivity in concentrations that were 10 to 100 times less than the corresponding concentrations in the rat intestine. The hagfish gut also contained
glucagon
-like immunoreactivity, measured with both C- and N-terminally directed antisera, but the immunoreactivity did not dilute in parallel with the porcine
glucagon
standard in radio-immunoassay. No immunoreactivity was detected using antisera to calcitonin gene-related peptide, gastrin-releasing peptide, neuromedin U, neurotensin, N-terminal substance P, and vasoactive intestinal polypeptide. The somatostatin-like immunoreactivity in the hagfish gut was resolved by HPLC into components with the retention times of somatostatin-34 and somatostatin-14, previously isolated from the hagfish islet organ (relative abundance 2:1). The retention times of hagfish
glucagon
and of the multiple molecular forms of the tachykinin-like peptides were appreciably different from the retention times of the corresponding mammalian peptides.
Gen
Comp Endocrinol 1989 Nov
PMID:Neurohormonal peptides in the gut of the Atlantic hagfish (Myxine glutinosa) detected using antisera raised against mammalian regulatory peptides. 248 Feb 67
Kinetic characteristics of American eel liver 6-phosphofructo-1-kinase (PFK-1) and the effects of porcine insulin, bovine
glucagon
, and dibutyryl-cAMP were studied. At 0.1 mM ATP, kinetics were sigmoidal with respect to fructose-6-phosphate (F-6-P) concentrations and the S0.5 (F-6-P) increased with higher ATP concentrations. At 2 mM F-6-P, optimal ATP concentrations were 0.1 mM, with maximal inhibition at 0.5 mM. Fructose 2,6-bisphosphate (Fru-2,6-P2) offset ATP inhibition and activated the enzyme, changing F-6-P kinetic curves from sigmoidal to hyperbolic. At 2 mM F-6-P and 0.1 mM ATP the Fru-2,6-P2 activation curve was hyperbolic with a Ka of approximately 1 microM. In isolated hepatocytes, porcine insulin decreased the sensitivity of PFK-1 to ATP, an effect that was offset when bovine
glucagon
was also present. Insulin, alone and with
glucagon
, increased the Fru-2,6-P2 activation ratio. In the presence of
glucagon
, insulin increased Fru-2,6-P2 concentrations in hepatocytes. These effects suggest that PFK-1 is a potential regulatory point for hormones in the control of carbohydrate metabolism in the American eel liver.
Gen
Comp Endocrinol 1989 Mar
PMID:The regulation of 6-phosphofructo-1-kinase by insulin and glucagon in isolated hepatocytes of the American eel. 253 79
In vitro assessment was made of the hormone-release capability of splenic pancreatic tissue 16 days after adult chickens had 99% of the pancreatic mass surgically removed. The objective of this study was to evaluate if the enlargement of the splenic lobe remnant after 99% pancreatectomy was attended by alterations in the responsivity of hormone release and, if so, were such changes reflective of all pancreatic hormones. After a 24-hr fast, splenic lobe tissue was obtained from young adult chickens on Postoperative Day 16, diced into 18-22 mg cubes, and incubated in vitro in media containing varying amounts of glucose with or without added somatostatin (SRIF). At 15-min intervals, the tissue cubes were transferred to fresh media and samples of each medium measured for insulin,
glucagon
, and APP. Viability of the tissue after 75 min was tested by tissue response to added 5 mM phenylalanine. The results obtained indicated that while total content of all four hormones (including SRIF) increased with tissue enlargement, the concentration of each decreased significantly except for SRIF, which remained at control levels. Further, the sensitivity of the B-cell in releasing insulin when confronted by a glucose challenge was not altered by previous pancreatectomy, while that of
glucagon
release from the A-cell was depressed. A-cell responsivity to SRIF does not appear to be adversely affected by previous 99% pancreatectomy. APP release was least affected by SRIF addition to the media, although depression by high glucose occurred. It is concluded that differential alterations occur in chicken pancreatic hormone-releasing cells as a result of 99% pancreatectomy. The efficacy in maintaining low, but still adequate, plasma I/G molar ratios (reported earlier) by the splenic remnant tissue either reflects a remarkable functional readjustment to surgical removal of 99% of the pancreatic mass in chickens or, alternatively, suggests the existence of extrapancreatic sources of insulin and
glucagon
, but not APP.
Gen
Comp Endocrinol 1989 Feb
PMID:In vitro release of pancreatic hormones following 99% pancreatectomy in the chicken. 256 76
In the duck, subtotal pancreatectomy induces a transient diabetes, with decreased insulin and
glucagon
basal levels as well as responses to glucose. At the same time, a transient increase in basal peripheral somatostatin occurs, followed by an increase in growth hormone in the postdiabetic state. Intravenous glucose induces a slight decrease in somatostatin secretion in normal, but not in diabetic animals, and no significant variation in growth hormone secretion at any state. An obvious role of growth hormone or somatostatin in the development of this transient diabetes in the duck could not be detected in this study.
Gen
Comp Endocrinol 1989 May
PMID:Growth hormone and somatostatin in the plasma of transiently diabetic ducks: basal variation and response to glucose. 256 51
The comparative distribution of somatostatin- and
glucagon
-like-containing cells in the histomorphologically different gastric mucosae of the cartilaginous fishes Heptranchias perlo, Raja asterias, Scyliorhinus canicula, Squatina aculeata, and Torpedo marmorata was immunocytochemically studied to demonstrate a possible interrelationship between these endocrine cells and/or other endocrine or nonendocrine cells. In the gastric mucosa, these open-type
glucagon
and somatostatin immunoreactive cells show a double localization with different morphology and interrelationships. At the bottom of gastric pits, which corresponds to a proliferative zone, spindle or pear-shaped immunopositive cells appear rather numerously and are often in close proximity to each other. In gastric glands, triangular or oval immunopositive cells never in contact with each other were detected; their numeric ratio seems to be rather constant even if their numeric frequency and distribution vary according to the histomorphological aspect of selachian gastric glands.
Glucagon
immunoreactive cells seem to be more related to pepsinogenic cells, while somatostatin immunoreactive cells seem to be more ubiquitous. Both cell types can present basal cytoplasmic processes. From our results we can suggest a possible regulative role exerted by these two peptides on gastric secretion and cell proliferation.
Gen
Comp Endocrinol 1989 Jul
PMID:Distribution of somatostatin and glucagon immunoreactive cells in the gastric mucosa of some cartilaginous fishes. 257 6
The gastroenteropancreatic (GEP) endocrine system of three reptiles, Testudo graeca, Mauremys caspica, and Lacerta lepida, was investigated by means of immunocytochemistry. Single and double immunostaining methods have demonstrated immunoreactivity for insulin,
glucagon
, pancreatic polypeptide (PP), somatostatin, serotonin, and peptide tyrosine tyrosine (PYY) in endocrine cells of the pancreas of the reptiles studied. Islet-like structures with insulin-immunoreactive (IR) cells surrounded by
glucagon
-IR cells were observed only in the splenic portion of the pancreas of M. caspica. Occasionally, somatostatin- and PP-IR cells were associated with
glucagon
-containing cells. Endocrine cells were also observed in the excretory ducts of the exocrine glands. Serotonin, bombesin, neurotensin, gastrin,
glucagon
, somatostatin, PYY, and insulin were demonstrated immunocytochemically in open-type GEP cells of the digestive tract of the animals studied. Serotonin, somatostatin, and
glucagon
-immunoreactive cells were the most abundant endocrine cell types. In L. lepida, PP- and peptide tyrosine tyrosine-immunoreactive cells were also frequently observed. Cells containing cholecystokinin, gastric inhibitory peptide, met- and leu-enkephalin, motilin, secretin, and vasoactive intestinal peptide could not be detected. The present work demonstrates that the reptilian GEP endocrine system is a complex structure containing most of the regulatory peptides similar in structure to those found in higher vertebrates.
Gen
Comp Endocrinol 1989 Nov
PMID:Comparative immunohistochemical study of the gastroenteropancreatic endocrine system of three reptiles. 257 25
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>